Analystreport

Oncolytics Biotech, Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Royal Bank of Canada from $9.00 to $6.00. They now have an "outperform" rating on the stock.

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com